CN1385191A - Medicine for treating liver disease - Google Patents
Medicine for treating liver disease Download PDFInfo
- Publication number
- CN1385191A CN1385191A CN 02110483 CN02110483A CN1385191A CN 1385191 A CN1385191 A CN 1385191A CN 02110483 CN02110483 CN 02110483 CN 02110483 A CN02110483 A CN 02110483A CN 1385191 A CN1385191 A CN 1385191A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- fructus
- vinegar
- parched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 208000019423 liver disease Diseases 0.000 title claims abstract description 10
- 229940079593 drug Drugs 0.000 title description 5
- 235000021419 vinegar Nutrition 0.000 claims abstract description 12
- 239000000052 vinegar Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 241000756943 Codonopsis Species 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 11
- 239000010231 banlangen Substances 0.000 claims description 11
- 230000017531 blood circulation Effects 0.000 claims description 11
- 239000012266 salt solution Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 abstract description 7
- 206010016654 Fibrosis Diseases 0.000 abstract description 3
- 230000004761 fibrosis Effects 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 241000700605 Viruses Species 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- 230000003908 liver function Effects 0.000 abstract description 2
- 238000005498 polishing Methods 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 241000594394 Hedyotis Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 210000005229 liver cell Anatomy 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- -1 tableting Substances 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001147 anti-toxic effect Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000018191 liver inflammation Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000005482 chemotactic factor Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine for curing liver disease is made of 15 Chinese medicinal materials of isatis root, hedyotis, salted phellodendron, gentian root, huoxuelong, bupleurum root mix-fried with vinegar, Chinese angelica root and others. Its preparation method includes the following steps: soaking raw materials, decocting at twice respectively for 1-3 hr, and 1-2 hr., filtering and combining both decoctions, concentrating to obtain paste material, tableting, coating, polishing and drying so as to obtain the invented product. It can quickly kill virus, quickly restore liver function and can resist liver cell fibrosis.
Description
Technical field
The present invention relates to medicine, is a kind of medicine for the treatment of hepatopathy.
Background technology
At present, the hepatitis B patient is the district occurred frequently in China, and particularly the chronic viral hepatitis B patient is more, and health is produced bigger harm.The medicine of treatment hepatitis B disease be generally Western medicine, and the side effect of Western medicine is bigger, costs an arm and a leg, and therapeutic effect is not remarkable.
The objective of the invention is, a kind of main treatment chronic viral hepatitis B patient's medicine is provided, it have go out that poison is fast, liver power recovery is fast, antitoxin, nourishing the liver, prevention hepatocyte fibrosis and alleviate advantage such as liver inflammation function.
The present invention is for finishing the foregoing invention purpose, the technical scheme that provides is a kind of medicine for the treatment of hepatopathy, and the raw materials used proportioning of its medicine is (consumption is a weight portion): Radix Isatidis 2-10, Herba Hedyotidis Diffusae 2-10, stir-baked CORTEX PHELLODENDRI with salt solution 2-10, Radix Gentianae 1-5, the imperial 3-9 that invigorates blood circulation, Radix Bupleuri (processed with vinegar) 2-10, Radix Angelicae Sinensis 2-6, Rhizoma Atractylodis Macrocephalae (parched) 1-4, Fructus Jujubae 1-5 piece, Radix Salviae Miltiorrhizae 2-10, Radix Codonopsis 1-4, Radix Astragali Preparata 2-10, Fructus Lycii 2-10, Fructus Schisandrae Chinensis 2-6, Radix Glycyrrhizae 2-6.Described a kind of medicine for the treatment of hepatopathy, the raw materials used proportioning of its medicine are (consumption are a weight portion): Radix Isatidis 4-6, Herba Hedyotidis Diffusae 4-6, stir-baked CORTEX PHELLODENDRI with salt solution 3-5, Radix Gentianae 1-3, the imperial 4-7 that invigorates blood circulation, Radix Bupleuri (processed with vinegar) 4-6, Radix Angelicae Sinensis 4-6, Rhizoma Atractylodis Macrocephalae (parched) 1-3, Fructus Jujubae 1-3 piece, Radix Salviae Miltiorrhizae 4-6, Radix Codonopsis 1-3, Radix Astragali Preparata 4-6, Fructus Lycii 4-6, Fructus Schisandrae Chinensis 3-5, Radix Glycyrrhizae 4-6.Described a kind of medicine for the treatment of hepatopathy, the raw materials used proportioning of its medicine are (consumption are a weight portion): Radix Isatidis 5, Herba Hedyotidis Diffusae 5, stir-baked CORTEX PHELLODENDRI with salt solution 5, Radix Gentianae 3, invigorate blood circulation dragon 6, Radix Bupleuri (processed with vinegar) 5, Radix Angelicae Sinensis 4, Rhizoma Atractylodis Macrocephalae (parched) 3,3 pieces in Fructus Jujubae, Radix Salviae Miltiorrhizae 5, Radix Codonopsis 2, Radix Astragali Preparata 5, Fructus Lycii 5, Fructus Schisandrae Chinensis 4, Radix Glycyrrhizae 4.
The preparation method of medicine of the present invention is: the said medicine raw material is pressed above-mentioned described weight portion, soak according to a conventional method, add 7-9 times of decocting by dose then and boiled 1-3 hour, taking liquid is standby, the 6-8 times of decocting that adds dose again boiled 1-2 hour, the filter medicinal liquid, the medicinal liquid of twice decoction is complete and be concentrated into the thick paste shape, adopt known technology to carry out tabletting then, make every to contain crude drug 0.4 gram, last sugar coating, the polishing drying is made coated tablet.Medicine of the present invention also can be made into electuary, and the method for making electuary is identical with known Chinese medicine electuary preparation method.
Medicine of the present invention also can increase Radix Arnebiae (Radix Lithospermi) 2-11, Poria 3-12, Herba Lycopi 1-5, silkworm excrement 1-4 on said medicine raw material basis, improve the ability of liver function and reach the effect that diminishes inflammation to increase it.
The present invention is through clinical proof of more than ten years, and the treatment chronic hepatitis B was taken medicine 3 months, and total effective rate is 96.6% in the recent period, and cure rate is 87.7%, and drug withdrawal tracing study at a specified future date is after 15 months, and total effective rate is 93.5%, and stable curative effect has no side effect.Medicine treating both the principal and secondary aspects of a disease of the present invention has antitoxin, nourishing the liver, prevention fibrosis and alleviates the advantage of liver inflammation function, but and enhance immunity, inducement interferon, antagonism chemotactic factor and remove oxygen-derived free radicals, to suppress and to eliminate hepatitis virus.
The specific embodiment
Embodiment 1, and following medicine material proportioning is weight portion:
Radix Isatidis 2-10, Herba Hedyotidis Diffusae 2-10, stir-baked CORTEX PHELLODENDRI with salt solution 2-10, Radix Gentianae 1-5, the imperial 3-9 that invigorates blood circulation, Radix Bupleuri (processed with vinegar) 2-10, Radix Angelicae Sinensis 2-6, Rhizoma Atractylodis Macrocephalae (parched) 1-4, Fructus Jujubae 1-5 piece, Radix Salviae Miltiorrhizae 2-10, Radix Codonopsis 1-4, Radix Astragali Preparata 2-10, Fructus Lycii 2-10, Fructus Schisandrae Chinensis 2-6, Radix Glycyrrhizae 2-6.
Embodiment 2, and following medicine material proportioning is weight portion:
Radix Isatidis 4-6, Herba Hedyotidis Diffusae 4-6, stir-baked CORTEX PHELLODENDRI with salt solution 3-5, Radix Gentianae 1-3, the imperial 4-7 that invigorates blood circulation, Radix Bupleuri (processed with vinegar) 4-6, Radix Angelicae Sinensis 4-6, Rhizoma Atractylodis Macrocephalae (parched) 1-3, Fructus Jujubae 1-3 piece, Radix Salviae Miltiorrhizae 4-6, Radix Codonopsis 1-3, Radix Astragali Preparata 4-6, Fructus Lycii 4-6, Fructus Schisandrae Chinensis 3-5, Radix Glycyrrhizae 4-6.
Embodiment 3, and following medicine material proportioning is weight portion:
Radix Isatidis 5, Herba Hedyotidis Diffusae 5, stir-baked CORTEX PHELLODENDRI with salt solution 5, Radix Gentianae 3, invigorate blood circulation dragon 6, Radix Bupleuri (processed with vinegar) 5, Radix Angelicae Sinensis 4, Rhizoma Atractylodis Macrocephalae (parched) 3,3 pieces in Fructus Jujubae, Radix Salviae Miltiorrhizae 5, Radix Codonopsis 2, Radix Astragali Preparata 5, Fructus Lycii 5, Fructus Schisandrae Chinensis 4, Radix Glycyrrhizae 4.
Embodiment 4, and following medicine material proportioning is weight portion:
Radix Isatidis 3, Herba Hedyotidis Diffusae 9, stir-baked CORTEX PHELLODENDRI with salt solution 2, Radix Gentianae 2, invigorate blood circulation dragon 3, Radix Bupleuri (processed with vinegar) 8, Radix Angelicae Sinensis 6, Rhizoma Atractylodis Macrocephalae (parched) 8,5 pieces in Fructus Jujubae, Radix Salviae Miltiorrhizae 10, Radix Codonopsis 10, Radix Astragali Preparata 4, Fructus Lycii 8, Fructus Schisandrae Chinensis 2, Radix Glycyrrhizae 2.
Embodiment 5, and following medicine material proportioning is weight portion:
Radix Isatidis 3-10, Herba Hedyotidis Diffusae 3-10, stir-baked CORTEX PHELLODENDRI with salt solution 2-8, Radix Gentianae 1-4, the imperial 4-6 that invigorates blood circulation, Radix Bupleuri (processed with vinegar) 3-5, Radix Angelicae Sinensis 3-5, Rhizoma Atractylodis Macrocephalae (parched) 1-2, Fructus Jujubae 1-2 piece, Radix Salviae Miltiorrhizae 3-5, Radix Codonopsis 1-2, Radix Astragali Preparata 2-5, Fructus Lycii 2-5, Fructus Schisandrae Chinensis 1-4, Radix Glycyrrhizae 2-5.
Claims (3)
1, a kind of medicine for the treatment of hepatopathy is characterized in that: the raw materials used proportioning of its medicine is (consumption is a weight portion): Radix Isatidis 2-10, Herba Hedyotidis Diffusae 2-10, stir-baked CORTEX PHELLODENDRI with salt solution 2-10, Radix Gentianae 1-5, the imperial 3-9 that invigorates blood circulation, Radix Bupleuri (processed with vinegar) 2-10, Radix Angelicae Sinensis 2-6, Rhizoma Atractylodis Macrocephalae (parched) 1-4, Fructus Jujubae 1-5 piece, Radix Salviae Miltiorrhizae 2-10, Radix Codonopsis 1-4, Radix Astragali Preparata 2-10, Fructus Lycii 2-10, Fructus Schisandrae Chinensis 2-6, Radix Glycyrrhizae 2-6.
2, a kind of medicine for the treatment of hepatopathy according to claim 1 is characterized in that: the raw materials used proportioning of its medicine is (consumption is a weight portion): Radix Isatidis 4-6, Herba Hedyotidis Diffusae 4-6, stir-baked CORTEX PHELLODENDRI with salt solution 3-5, Radix Gentianae 1-3, the imperial 4-7 that invigorates blood circulation, Radix Bupleuri (processed with vinegar) 4-6, Radix Angelicae Sinensis 4-6, Rhizoma Atractylodis Macrocephalae (parched) 1-3, Fructus Jujubae 1-3 piece, Radix Salviae Miltiorrhizae 4-6, Radix Codonopsis 1-3, Radix Astragali Preparata 4-6, Fructus Lycii 4-6, Fructus Schisandrae Chinensis 3-5, Radix Glycyrrhizae 4-6.
3, a kind of medicine for the treatment of hepatopathy according to claim 1 is characterized in that: the raw materials used proportioning of its medicine is (consumption is a weight portion): Radix Isatidis 5, Herba Hedyotidis Diffusae 5, stir-baked CORTEX PHELLODENDRI with salt solution 5, Radix Gentianae 3, invigorate blood circulation dragon 6, Radix Bupleuri (processed with vinegar) 5, Radix Angelicae Sinensis 4, Rhizoma Atractylodis Macrocephalae (parched) 3,3 pieces in Fructus Jujubae, Radix Salviae Miltiorrhizae 5, Radix Codonopsis 2, Radix Astragali Preparata 5, Fructus Lycii 5, Fructus Schisandrae Chinensis 4, Radix Glycyrrhizae 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110483 CN1228063C (en) | 2002-06-04 | 2002-06-04 | Medicine for treating liver disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110483 CN1228063C (en) | 2002-06-04 | 2002-06-04 | Medicine for treating liver disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1385191A true CN1385191A (en) | 2002-12-18 |
| CN1228063C CN1228063C (en) | 2005-11-23 |
Family
ID=4741103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02110483 Expired - Fee Related CN1228063C (en) | 2002-06-04 | 2002-06-04 | Medicine for treating liver disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1228063C (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100409865C (en) * | 2006-05-30 | 2008-08-13 | 夏金陵 | Compound medicine for treating hepatitis B |
| CN100431572C (en) * | 2006-04-11 | 2008-11-12 | 昆明医学院 | Application of Kudancao in use for resisting lung fibrosis |
| CN102178789A (en) * | 2011-04-26 | 2011-09-14 | 刘明述 | Hepatitis B virus resistant traditional Chinese medicine composition and preparation method thereof |
| CN103751577A (en) * | 2013-12-23 | 2014-04-30 | 孙丽 | Traditional Chinese medicine for treating liver phlegm stagnation type hepatopathy |
| CN104306550A (en) * | 2014-09-30 | 2015-01-28 | 青岛百瑞吉生物工程有限公司 | Application of traditional Chinese medicine composition in preparing liver-protecting medicine |
| CN104306549A (en) * | 2014-09-30 | 2015-01-28 | 青岛百瑞吉生物工程有限公司 | Traditional Chinese medicine composition with function of dispelling effect of alcohol and preparation method thereof |
| CN104435710A (en) * | 2014-11-26 | 2015-03-25 | 黑龙江省智诚医药科技有限公司 | Traditional Chinese medicine dispersible tablet capable of soothing liver and strengthening spleen, and preparation method of dispersible tablet |
| CN106110195A (en) * | 2016-07-27 | 2016-11-16 | 牡丹江医学院红旗医院 | Hyperbaric oxygentherapy strengthens physical ability Chinese medicine composition and preparation method |
-
2002
- 2002-06-04 CN CN 02110483 patent/CN1228063C/en not_active Expired - Fee Related
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100431572C (en) * | 2006-04-11 | 2008-11-12 | 昆明医学院 | Application of Kudancao in use for resisting lung fibrosis |
| CN100409865C (en) * | 2006-05-30 | 2008-08-13 | 夏金陵 | Compound medicine for treating hepatitis B |
| CN102178789A (en) * | 2011-04-26 | 2011-09-14 | 刘明述 | Hepatitis B virus resistant traditional Chinese medicine composition and preparation method thereof |
| CN102178789B (en) * | 2011-04-26 | 2012-08-22 | 刘明述 | Hepatitis B virus resistant traditional Chinese medicine composition and preparation method thereof |
| CN103751577A (en) * | 2013-12-23 | 2014-04-30 | 孙丽 | Traditional Chinese medicine for treating liver phlegm stagnation type hepatopathy |
| CN104306550A (en) * | 2014-09-30 | 2015-01-28 | 青岛百瑞吉生物工程有限公司 | Application of traditional Chinese medicine composition in preparing liver-protecting medicine |
| CN104306549A (en) * | 2014-09-30 | 2015-01-28 | 青岛百瑞吉生物工程有限公司 | Traditional Chinese medicine composition with function of dispelling effect of alcohol and preparation method thereof |
| CN104435710A (en) * | 2014-11-26 | 2015-03-25 | 黑龙江省智诚医药科技有限公司 | Traditional Chinese medicine dispersible tablet capable of soothing liver and strengthening spleen, and preparation method of dispersible tablet |
| CN106110195A (en) * | 2016-07-27 | 2016-11-16 | 牡丹江医学院红旗医院 | Hyperbaric oxygentherapy strengthens physical ability Chinese medicine composition and preparation method |
| CN106110195B (en) * | 2016-07-27 | 2020-01-07 | 牡丹江医学院红旗医院 | Traditional Chinese medicine composition for enhancing physical performance through hyperbaric oxygen treatment and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1228063C (en) | 2005-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN102319408B (en) | Chinese medicine for strengthening spleen, eliminating dampness and treating gastroptosis and extraction method thereof | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN1228063C (en) | Medicine for treating liver disease | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN1063954C (en) | Chinese patent medicine-powder preparation for curing hepatitis B | |
| CN103142920A (en) | Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof | |
| CN102327572A (en) | Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN105031106A (en) | Lavipeditum powder for relieving fatigue and preparation method thereof | |
| CN101152540A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN1057230C (en) | Traditional Chinese medicine capsule for treating thrombophlebitis | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN1280835A (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
| CN105521150A (en) | Preparation method traditional Chinese medicine for reducing blood fat | |
| CN1151813C (en) | Traditional Chinese medicine composition for curing insomnia | |
| CN1322558A (en) | an anti-cancer drug | |
| CN1051460C (en) | Medicine for treatment of leukoderma and its preparing method | |
| CN103393954A (en) | Preparation method of ointment for helping rehabilitation of peroneal nerve injury | |
| CN1228062C (en) | Medicine for treating liver disease | |
| CN109833402B (en) | A kind of Shaoyao Dan anti-inflammatory liver-protecting wine and preparation method thereof | |
| CN1377678A (en) | Traditional Chinese medicine particulate preparation for curing cardiovascular and cerebrovascular diseases and its preparing method | |
| CN101721582A (en) | Traditional Chinese medicine honeyed pill for treating hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |